RESUMEN
BACKGROUND: Attentional bias may influence the emotional experiences of breast cancer patients, both positively and negatively. This study aimed to investigate attentional bias in breast cancer patients and its impact on their emotions. METHOD: Thirty-eight breast cancer patients completed a modified dot-probe task and the Depression Anxiety and Stress Scale to assess attentional bias and emotional states. Attentional bias was measured by analyzing response times to different stimuli in the modified dot-probe task. Emotional stimuli included 80 pairs of facial images depicting sad-neutral, fearful-neutral, happy-neutral, and neutral-neutral expressions. Attentional bias components were observed at stimulus presentation durations of 300 ms and 1500 ms. Differences in emotional responses among breast cancer patients with varying attentional biases were compared. RESULTS: Breast cancer patients exhibited attentional avoidance of sad and happy stimuli at 300 ms. Further analysis revealed that patients who exhibited attentional avoidance of sad stimuli at 300 ms reported higher levels of anxiety and stress. Those with attentional avoidance of fearful stimuli at 1500 ms reported increased anxiety, while individuals showing attentional avoidance of happy stimuli or difficulty disengaging from happy stimuli at 1500 ms reported higher levels of depression and stress. CONCLUSION: Breast cancer patients demonstrated an attentional bias toward emotional stimuli, particularly avoidance of sad and happy stimuli in 300 ms. Different components of attentional bias were associated with distinct negative emotional outcomes.
RESUMEN
Background: Psychological distress is highly prevalent and has a severe impact on the quality of life among breast cancer survivors. This type of distress is associated with cognitive failure. However, previous studies have focused solely on the total scale scores of these two concepts while ignoring the unique relationship between specific components. In the present study, we utilized network analysis to explore the relationship between psychological distress and cognitive failure in breast cancer survivors. Methods: The network analysis approach was adopted to estimate the regularized partial correlation network in a cross-sectional sample of 409 breast cancer survivors. All participants were assessed using the Depression Anxiety Stress Scale and the Cognitive Failure Questionnaire. The Gaussian Graphical Model was employed to estimate the network, centrality indices, and edge weights, providing a description of the characteristics of the network. Results: The results indicated that anxiety-stress and depression-stress were the strongest edges in the community of psychological distress. Distractibility-memory was the strongest edge in the community of cognitive failure. Distractibility and memory were the most central nodes, with the highest expected influence in the network. Depression and motor coordination acted as important bridge nodes with the highest bridge expected influence. Conclusion: Distractibility and memory in cognitive failure played important roles in activating and maintaining the relationship network. Motor coordination was identified as the crucial pathway for the impact of cognitive failure on psychological distress. Interventions targeting these specific issues might be more effective in improving cognitive failure and reducing psychological distress among breast cancer survivors.
RESUMEN
Stroke is a leading cause of death and disability in the world. Astrocytes are special glial cells within the central nervous system and play important roles in mediating neuroprotection and repair processes during stroke. Extracellular vesicles (EVs) are lipid bilayer particles released from cells that facilitate intercellular communication in stroke by delivering proteins, lipids, and RNA to target cells. Recently, accumulating evidence suggested that astrocyte-derived EVs (ADEVs) are actively involved in mediating numerous biological processes including neuroprotection and neurorepair in stroke and they are realized as an excellent therapeutic approach for treating stroke. In this review we systematically summarize the up-to-date research on ADEVs in stroke, and prospects for its potential as a novel therapeutic target for stroke. We also provide an overview of the effects and functions of ADEVs on stroke recovery, which may lead to developing clinically relevant therapies for stroke.